xMAP® Multiplex Assays Enable HIV Research

As the causative agent of the acquired immune deficiency syndrome (AIDS) pandemic, HIV has been the focus of intense research for more than 30 years. In this white paper, learn how the reproducible, fast, sensitive, and highly-multiplexed assays for nucleic acid sequences, antigens, antibodies, and cytokine levels based on Luminex® xMAP® Technology provide optimal solutions for understanding HIV infection and development of a vaccine.